Linzagolix

Linzagolix is a new oral medicine used to treat heavy menstrual bleeding associated with uterine fibroids in women. It works by blocking the production of certain hormones in the body that stimulate the growth of fibroids and cause heavy menstrual bleeding. It can be taken once daily and has been shown to reduce heavy menstrual bleeding and improve quality of life in women with uterine fibroids.

Linzagolix is a medication used to treat uterine fibroids in adult women of reproductive age. It is sold under the brand name Yselty. Here's a breakdown of how it works:

• Type of drug: Linzagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist.
• How it works: It works by attaching to and blocking the GnRH receptor in the pituitary gland. This disrupts the normal hormonal communication between the brain, pituitary gland, and ovaries.
• Effects: This disruption leads to a decrease in the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones normally stimulate the ovaries to produce estrogen, which fuels the growth of uterine fibroids. By lowering estrogen levels, linzagolix helps shrink fibroids and manage symptoms like heavy bleeding, pelvic pain, and pressure.

Important points to note:

• Linzagolix is currently approved for uterine fibroids in the EU. It is under review for the same use in the USA.
• Linzagolix is being studied for the treatment of endometriosis-associated pain, but it's not yet approved for this use.
• It's taken orally.

Since linzagolix impacts hormones, it's crucial to consult with a doctor to see if it's suitable for you and discuss any potential side effects.